Drug
Who makes insulin glargine-yfgn?
2 companies list insulin glargine-yfgn as a human prescription drug, including under the names SEMGLEE. Forms: injection, solution. Routes: subcutaneous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing insulin glargine-yfgn
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Biocon Biologics LimitedIndia | injection, solution | BLABLA761201 | 4 | 9 |
| Civica, Inc. dba CivicaRxUnited States | injection, solution | BLABLA761201 | 2 | 1 |
Enquiry
Common questions
- Who makes insulin glargine-yfgn?
- 2 companies list insulin glargine-yfgn as a human prescription drug in the openFDA NDC Directory, led by Biocon Biologics Limited, Civica, Inc. dba CivicaRx. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.